1. Meador KJ. Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res. 2006. 68:63–7.
4. Salinsky MC, Storzbach D, Dodrill CB, Binder LM. Test-retest bias, reliability, and regression equations for neuropsychological measures repeated over a 12–16-week period. J Int Neuropsychol Soc. 2001. 7:597–605.
5. Cho JR, Koo DL, Joo EY, et al. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients. Clin Neurophysiol. 2012. 123:883–91.
6. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia. 2002. 43:482–90.
7. Salinsky MC, Oken BS, Storzbach D, Dodrill CB. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia. 2003. 44:1042–50.
8. Clemens B, Menes A, Piros P, et al. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings. Epilepsy Res. 2006. 70:190–9.
9. Clemens B, Ménes A, Nagy Z. Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine. Acta Neurol Scand. 2004. 109:324–9.
10. Adler G, Brassen S, Jajcevic A. EEG coherence in Alzheimer’s dementia. J Neural Transm. 2003. 110:1051–8.
11. Fonseca LC, Tedrus GM, Prandi LR, Almeida AM FD. Alzheimer’s disease: relationship between cognitive aspects and power and coherence EEG measures. Arq Neuropsiquiatr. 2011. 69:875–81.
12. Moller DW, Chiu AWL. Noise-assisted intrinsic mode function coherence in seizure anticipation. Conf Proc IEEE Eng Med Biol Soc. 2011. 2011:8287–90.
13. Tcheslavski GV, Gonen FF. Alcoholism-related alterations in spectrum, coherence, and phase synchrony of topical electroencephalogram. Comput Biol Med. 2012. 42:394–401.
15. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989. 30:389–99.
16. Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004. 134:9–21.
17. Wechlser D. Wechsler memory scale-Revised manual. San Antonio, TX: The Psychological Corporation; 1987.
18. Kim H, Na D. Parallel Short Forms for the Korean-Boston Naming Test (K-BNT). Seoul: Hakjisa; 2000.
19. Meyers JE, Meyers KR. Rey complex figure test and recognition trial. Psychological assessment resources Inc; 1995.
20. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery theory and interpretation. Neuropsychology Press; 1985.
21. Kim JK, Kang YW. Korean-California verbal learning test. Seoul: Special Education; 1997.
22. Kang Y, Na D. Seoul neuropsychological screening battery. Seoul: Human Brain Research & Consulting; 2003.
23. Lee J, Kang Y, Na D. Efficiencies of the Stroop interference indexes in healthy older adults and dementia patients. Korean J Clin Psychol. 2000. 19:807–18.
24. Stephens R, Kaufman A. The role of long-term memory in digit-symbol test performance in young and older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2009. 16:219–40.
25. Wechsler D. Wechsler Adult Intelligence Scale - revised manual. New York: The Psychological Corporation; 1981.
26. Reitan RM. Trail making test: manual for administration and scoring. Tucson AZ: Neuropsychology Press; 1992.
27. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin card sorting test manual revised and expanded. Lutz, FL: Psychological Assessment Resources, Inc; 1993.
28. Tzitiridou M, Panou T, Ramantani G, Kambas A, Spyroglou K, Panteliadis C. Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation. Epilepsy Behav. 2005. 7:458–67.
29. Donati F, Gobbi G, Campistol J, et al. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure. 2007. 16:670–79.
31. Curran HV, Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol. 1993. 44:529–33.
32. Bullock TH, McClunea MC. Lateral coherence of the electrocorticogram: a new measure of brain synchrony. Electroencephalogr Clin Neurophysiol. 1989. 73:479–98.
34. Alonso JF, Mañanas MA, Romero S, Hoyer D, Riba J, Barbanoj MJ. Drug effect on EEG connectivity assessed by linear and nonlinear couplings. Hum Brain Mapp. 2010. 31:487–97.
35. Salinsky MC, Spencer DC, Oken BS, Storzbach D. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav. 2004. 5:894–902.
36. Herkes GK, Lagerlund TD, Sharbrough FW EM. Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients. J Clin Neurophysiol. 1993. 10:210–6.
37. Meador KJ, Loring DW, Abney OL, Allen ME, Moore EE, Zamrini EY KD. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia. 1993. 34:153–7.
38. Frost JD, Hrachovy RA, Glaze DG, Rettig GM. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. J Clin Neurophysiol. 1995. 12:57–63.
39. Mecarelli O, Vicenzini E, Pulitano P, et al. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Ann Pharmacother. 2004. 38:1816–22.
40. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia. 2002. 43:482–90.
41. Besser R, Hornung K, Theisohn M, Rothacher G, Krämer G. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol. 1992. 83:19–23.
42. Mecarelli O, Piacenti A, Pulitano P, et al. Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers. Clin Neuropharmacol. 2001. 24:284–9.
43. Neufeld MY, Kogan E, Chistik V, Korczyn AD. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy. Clin Neuropharmacol. 1999. 22:80–6.
44. Placidi F, Tombini M, Romigi A, et al. Topiramate: effect on EEG in-terictal abnormalities and background activity in patients affected by focal epilepsy. Epilepsy Res. 2004. 58:43–52.
45. Salinsky M, Storzbach D, Oken B, Spencer D. Topiramate effects on the EEG and alertness in healthy volunteers: a different profile of an-tiepileptic drug neurotoxicity. Epilepsy Behav. 2007. 10:463–9.
46. Smith ME, Gevins A, Mcevoy LK, Meador KJ, Ray PG, Gilliam F. Distinct Cognitive Neurophysiologic Profiles for Lamotrigine and Topiramate. Epilepsia. 2006. 47:695–703.
47. Roh JH, Park MH, Ko D, et al. Region and frequency specific changes of spectral power in Alzheimer’s disease and mild cognitive impairment. Clin Neurophysiol. 2011. 122:2169–76.
48. Herkes GK, Lagerlund TD, Sharbrough FW, Eadie MJ. Effects of Antiepileptic Drug Treatment on the Background Frequency of EEGs in Epileptic Patients. J Clin Neurophysiol. 1993. 10:210–6.
49. Veauthier J, Haettig H, Meencke HJ. Impact of levetiracetam add-on therapy on different EEG occipital frequencies in epileptic patients. Seizure. 2009. 18:392–5.
50. Béla C, Mónika B, Márton T, István K. Valproate selectively reduces EEG activity in anterior parts of the cortex in patients with idiopathic generalized epilepsy. A low resolution electromagnetic tomography (LORETA) study. Epilepsy Res. 2007. 75:186–91.
51. Meador KJ, Baker GA. Behavioral and Cognitive Effects of Lamotrigine. J Child Neurol. 1997. 12:44–7.
52. Meador K, Loring D, Ray P, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology. 2001. 56:1177–82.